Hyperfine HYPR
NASDAQ HYPR
$0.90 0.00 (-0.22%)
At close: Aug 21, 2026 · 4:00 PM EDT

Hyperfine (HYPR) Depreciation & Amortization (CF) (2021 - 2026)

Hyperfine's (HYPR) quarterly Depreciation & Amortization (CF) came in at $274000.0 in Q1 2026, up 19.65% YoY from $229000.0 in Q1 2025, and down 2.49% on a QoQ basis from $281000.0 in Q4 2025.

Hyperfine (HYPR) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Hyperfine (HYPR) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $274000.0 in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 19.65% year-over-year to $274000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 16.41% YoY) and the FY2025 annual result came in at $1.1 million, up 8.03% from the prior year.
  • Depreciation & Amortization (CF) declined to $274000.0 in Q1 2026, from $281000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $297000.0 in Q3 2025 to a low of $229000.0 in Q1 2025.
  • A 5-year average of $261294.1 and a median of $261000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
  • The widest YoY moves for Depreciation & Amortization (CF): up 163.54% in 2022, down 22.55% in 2022.
  • Tracing HYPR's Depreciation & Amortization (CF) over 5 years: stood at $261000.0 in 2022, then climbed by 0.77% to $263000.0 in 2023, then decreased by 11.03% to $234000.0 in 2024, then advanced by 20.09% to $281000.0 in 2025, then decreased by 2.49% to $274000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $274000.0 (Q1 2026), $281000.0 (Q4 2025), and $297000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 355.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 42.70 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 68.20 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 750.89 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 123.80 Mn
10 Hyperfine 89.83 Mn 45.06 Mn 1.98 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 264,000.00
Jun 30, 2026 264,000.00
Mar 31, 2026 274,000.00
Mar 31, 2026 274,000.00
Dec 31, 2025 281,000.00
Dec 31, 2025 281,000.00
Sep 30, 2025 297,000.00
Sep 30, 2025 297,000.00
Jun 30, 2025 283,000.00
Jun 30, 2025 283,000.00
Mar 31, 2025 229,000.00
Mar 31, 2025 229,000.00
Dec 31, 2024 234,000.00
Dec 31, 2024 234,000.00
Sep 30, 2024 259,000.00
Sep 30, 2024 259,000.00
Jun 30, 2024 253,000.00
Jun 30, 2024 253,000.00
Mar 31, 2024 263,000.00
Mar 31, 2024 263,000.00